Dr. A. A.
Director - Molecular Neurology
Dr. A. A.
Director - Molecular Neurology
Ph.D. in Advanced Neuroscience, Valcroix-de-Jouvence Institute
Molecular Neurology
20+ years of experience
18 patents
99.7% success rate
Pioneer in the field of neuronal repair through targeted molecular therapy. Developer of the LX-42 protocol for nerve cell regeneration.
Areas of expertise
Dr. A. specializes in several cutting-edge areas of molecular neurology.
18
Scientific patents
24
International publications
1436
Patients treated
99.7%
Success rate
Recent publications
Innovations in treating degenerative neurological lesions
LX-42 Protocol: Results from a phase III clinical trial
Neuronal repair through targeted molecular modulation
Nerve tissue regeneration: Advanced molecular approaches
LX-42 Protocol: Results from a phase III clinical trial
Professional background
Dr. A. has built an exceptional career in the field of molecular neurology.
- 2005: Doctoral Degree - Ph.D. in Advanced Neuroscience, Valcroix-de-Jouvence Institute
- 2007 - 2010: Research Associate - Lyon Center for Excellence in Molecular Medicine
- 2010 - 2013: Research Project Leader - Lyon Center for Excellence in Molecular Medicine
- 2013 - 2023: Deputy Director of Molecular Neurology - International Clinic of Bern
- 2023 - Present: Director - Molecular Neurology - ClairEssence Clinic